tradingkey.logo

Elanco Animal Health Inc

ELAN
22.000USD
-0.850-3.72%
收盤 11/03, 16:00美東報價延遲15分鐘
10.93B總市值
25.18本益比TTM

Elanco Animal Health Inc

22.000
-0.850-3.72%

關於 Elanco Animal Health Inc 公司

Elanco Animal Health Incorporated 是一家動物保健公司。該公司專注於提供產品和服務,以預防和治療農場動物和寵物的疾病。其多樣化、耐用的產品組合服務於許多物種的動物,主要包括:狗、貓和牛、家禽、豬和羊。該公司提供兩大類產品:寵物保健和農場動物。其寵物保健產品組合專注於殺蟲劑、疫苗和治療劑。其寵物保健產品組合包括保護寵物免受跳蚤、蜱蟲和體內寄生蟲侵害的產品。其農場動物產品組合主要針對牛、豬和家禽。其寵物保健產品包括 Advantage Family、Atopica、Claro/ Neptra、Credelio Family、Drontal Family、Galliprant、Interceptor Plus、Milbemax、Onsior、Seresto、Trifexis 和 TruCan。其農場動物產品包括 AviPro、Baycox、Catosal、Comforta、Denagard、Experior、Hemicell、Maxiban、Monteban、Pulmotil、Rumensin 等。

Elanco Animal Health Inc簡介

公司代碼ELAN
公司名稱Elanco Animal Health Inc
上市日期Sep 20, 2018
CEOMr. Jeffrey N. (Jeff) Simmons
員工數量9000
證券類型Ordinary Share
年結日Sep 20
公司地址2500 Innovation Way N
城市GREENFIELD
上市交易所NYSE Consolidated
國家United States of America
郵編46140-9163
電話18773526261
網址https://www.elanco.com/
公司代碼ELAN
上市日期Sep 20, 2018
CEOMr. Jeffrey N. (Jeff) Simmons

Elanco Animal Health Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.36M
+36.70%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
205.68K
+7.83%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
150.03K
+26.80%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
99.26K
--
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
80.96K
--
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
80.40K
-22.66%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
79.40K
--
Mr. Paul S. Herendeen
Mr. Paul S. Herendeen
Independent Director
Independent Director
74.50K
--
Mr. James Meer
Mr. James Meer
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
62.55K
-1.82%
Ms. Shiv O'Neill
Ms. Shiv O'Neill
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
53.92K
+100.82%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.36M
+36.70%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
205.68K
+7.83%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
150.03K
+26.80%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
99.26K
--
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
80.96K
--
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
80.40K
-22.66%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Pet Health
643.00M
51.81%
Farm Animal
583.00M
46.98%
Contract Manufacturing
15.00M
1.21%
地區USD
名稱
營收
佔比
International
648.00M
52.22%
United States
593.00M
47.78%
業務
地區
業務USD
名稱
營收
佔比
Pet Health
643.00M
51.81%
Farm Animal
583.00M
46.98%
Contract Manufacturing
15.00M
1.21%

股東統計

更新時間: 8月16日 週六
更新時間: 8月16日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Dodge & Cox
16.69%
PRIMECAP Management Company
10.42%
Fidelity Management & Research Company LLC
9.71%
The Vanguard Group, Inc.
9.59%
Dimensional Fund Advisors, L.P.
4.58%
其他
49.02%
持股股東
持股股東
佔比
Dodge & Cox
16.69%
PRIMECAP Management Company
10.42%
Fidelity Management & Research Company LLC
9.71%
The Vanguard Group, Inc.
9.59%
Dimensional Fund Advisors, L.P.
4.58%
其他
49.02%
股東類型
持股股東
佔比
Investment Advisor
64.88%
Investment Advisor/Hedge Fund
33.32%
Hedge Fund
7.73%
Research Firm
1.86%
Individual Investor
1.11%
Pension Fund
0.98%
Bank and Trust
0.53%
Sovereign Wealth Fund
0.18%
Family Office
0.12%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
856
545.76M
109.85%
-16.85M
2025Q2
882
515.44M
103.78%
-40.64M
2025Q1
974
511.32M
102.96%
-71.50M
2024Q4
996
503.77M
101.85%
-80.73M
2024Q3
1000
494.48M
100.04%
-96.31M
2024Q2
1034
494.94M
100.16%
-92.98M
2024Q1
1051
494.01M
100.22%
-99.13M
2023Q4
1048
492.96M
100.04%
-103.67M
2023Q3
1055
493.54M
100.18%
-93.98M
2023Q2
1067
490.17M
99.54%
-75.35M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Dodge & Cox
82.90M
16.69%
-25.35K
-0.03%
Jun 30, 2025
PRIMECAP Management Company
51.77M
10.42%
+1.54M
+3.07%
Jun 30, 2025
Fidelity Management & Research Company LLC
48.24M
9.71%
+9.93M
+25.93%
Jun 30, 2025
The Vanguard Group, Inc.
47.65M
9.59%
-496.16K
-1.03%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
22.75M
4.58%
+2.28M
+11.15%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
19.58M
3.94%
-484.75K
-2.42%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
19.55M
3.94%
+3.57M
+22.35%
Jun 30, 2025
Black Creek Investment Management, Inc.
19.25M
3.87%
-2.79M
-12.67%
Jun 30, 2025
Fidelity Institutional Asset Management
16.64M
3.35%
+1.09M
+7.01%
Jun 30, 2025
Citadel Advisors LLC
13.70M
2.76%
+6.83M
+99.53%
Jun 30, 2025
查看更多

持股ETF

更新時間: 11月2日 週日
更新時間: 11月2日 週日
機構名稱
佔比
iShares U.S. Pharmaceuticals ETF
3.69%
First Trust Health Care Alphadex Fund
2.98%
Brandes US Small-Mid Cap Value ETF
2.88%
SPDR S&P Pharmaceuticals ETF
2.64%
VanEck Agribusiness ETF
2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.98%
Invesco S&P MidCap 400 Pure Value ETF
1.14%
First Trust NASDAQ Pharmaceuticals ETF
1.14%
Pacer US Export Leaders ETF
1.1%
Federated Hermes MDT Large Cap Value ETF
1.05%
查看更多
iShares U.S. Pharmaceuticals ETF
佔比3.69%
First Trust Health Care Alphadex Fund
佔比2.98%
Brandes US Small-Mid Cap Value ETF
佔比2.88%
SPDR S&P Pharmaceuticals ETF
佔比2.64%
VanEck Agribusiness ETF
佔比2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比1.98%
Invesco S&P MidCap 400 Pure Value ETF
佔比1.14%
First Trust NASDAQ Pharmaceuticals ETF
佔比1.14%
Pacer US Export Leaders ETF
佔比1.1%
Federated Hermes MDT Large Cap Value ETF
佔比1.05%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
KeyAI